MPG.eBooks - Search Results

Cover Image

1941

Pharmacoeconomic review report: Tafamidis (Vyndaqel) (Pfizer Canada ULC) : indication: for the treatment of adult patients with cardiomyopathy due to transthyretin-mediated amyloid...

Published 2020

CADTH

Cover Image

1942

Clinical review report: Halobetasol propionate and tazarotene (Duobrii) : (Bausch Health, Canada Inc.) : indication : psoriasis, moderate-to-severe plaque

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1943

CADTH Canadian drug expert committee recommendation: Erenumab (Aimovig -- Novartis pharmaceuticals Canada Inc.) : indication: prevention of migraine

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1944

Clinical review report: Voretigene neparvovec (Luxturna) : (Novartis Pharmaceuticals Canada Inc.) : indication: vision loss, inherited retinal dystrophy

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

1945

Ketamine for sedation during bronchoscopy procedures : a review of clinical effectiveness, safety, and guidelines

by Banerjee, Srabani, McCormack, Suzanne
Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1946

CADTH Canadian Drug Expert Committee recommendation: Safinamide (Onstryv -- Valeo Pharma Inc.) : indication: for add-on therapy to a regimen that includes levodopa for the treatmen...

Published 2020

CADTH

Cover Image

1947

Canadian journal of health technologies

Published 2021

CADTH

Cover Image

1948

Clinical review report: Cabotegravir tablets, cabotegravir extended-release injectable suspension, and rilpivirine extended-release injectable suspension (Vocabria, Cuva) : (ViiV h...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1949

Target-controlled infusion with propofol and remifentanil for moderate procedural sedation in medicine and dentistry : a review of clinical effectiveness, cost-effectiveness, and g...

by Li, Yan, Picheca, Lory
Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1950

Pharmacoeconomic report: Etonogestrel extended-release subdermal implant (Nexplanon) : Merck Canada Inc. : indication: for the prevention of pregnancy

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1951

Clinical review report: Erenumab (Aimovig) (Novartis pharmaceuticals Canada Inc.) : indication: for prevention of migraine in patients who have had at least four migraine days mont...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Cover Image

1952

CADTH health technology assessment

Published 2015

Canadian Agency for Drugs and Technologies in Health

Cover Image

1953

Pharmacoeconomic report: Dapagliflozin (Forxiga) : (AstraZeneca Canada Inc.) : indication: heart failure with reduced ejection fraction

Published 2021

Canadian Agency for Drugs and Technologies in Health

Cover Image

1954

CADTH health technology review

Published 2021

Canadian Agency for Drugs and Technologies in Health

88
89
90
91
92
93
94
95
96
97
98